246 related articles for article (PubMed ID: 33402676)
21. A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase.
Segura-Cabrera A; Tripathi R; Zhang X; Gui L; Chou TF; Komurov K
Sci Rep; 2017 Mar; 7():44912. PubMed ID: 28322292
[TBL] [Abstract][Full Text] [Related]
22. Characterization of an Additional Binding Surface on the p97 N-Terminal Domain Involved in Bipartite Cofactor Interactions.
Hänzelmann P; Schindelin H
Structure; 2016 Jan; 24(1):140-147. PubMed ID: 26712280
[TBL] [Abstract][Full Text] [Related]
23. ATP binding to p97/VCP D1 domain regulates selective recruitment of adaptors to its proximal N-domain.
Chia WS; Chia DX; Rao F; Bar Nun S; Geifman Shochat S
PLoS One; 2012; 7(12):e50490. PubMed ID: 23226521
[TBL] [Abstract][Full Text] [Related]
24. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
Lan B; Chai S; Wang P; Wang K
Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
[TBL] [Abstract][Full Text] [Related]
25. Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4.
Meyer HH; Wang Y; Warren G
EMBO J; 2002 Nov; 21(21):5645-52. PubMed ID: 12411482
[TBL] [Abstract][Full Text] [Related]
26. The Cdc48 N-terminal domain has a molecular switch that mediates the Npl4-Ufd1-Cdc48 complex formation.
Oppenheim T; Radzinski M; Braitbard M; Brielle ES; Yogev O; Goldberger E; Yesharim Y; Ravid T; Schneidman-Duhovny D; Reichmann D
Structure; 2023 Jul; 31(7):764-779.e8. PubMed ID: 37311459
[TBL] [Abstract][Full Text] [Related]
27. Hierarchical binding of cofactors to the AAA ATPase p97.
Hänzelmann P; Buchberger A; Schindelin H
Structure; 2011 Jun; 19(6):833-43. PubMed ID: 21645854
[TBL] [Abstract][Full Text] [Related]
28. A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization.
Erzurumlu Y; Kose FA; Gozen O; Gozuacik D; Toth EA; Ballar P
Int J Biochem Cell Biol; 2013 Apr; 45(4):773-82. PubMed ID: 23333620
[TBL] [Abstract][Full Text] [Related]
29. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
Costantini S; Capone F; Polo A; Bagnara P; Budillon A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
[TBL] [Abstract][Full Text] [Related]
30. The AAA ATPase p97/VCP interacts with its alternative co-factors, Ufd1-Npl4 and p47, through a common bipartite binding mechanism.
Bruderer RM; Brasseur C; Meyer HH
J Biol Chem; 2004 Nov; 279(48):49609-16. PubMed ID: 15371428
[TBL] [Abstract][Full Text] [Related]
31. Comparison of force fields to study the zinc-finger containing protein NPL4, a target for disulfiram in cancer therapy.
Scrima S; Tiberti M; Ryde U; Lambrughi M; Papaleo E
Biochim Biophys Acta Proteins Proteom; 2023 Jul; 1871(4):140921. PubMed ID: 37230374
[TBL] [Abstract][Full Text] [Related]
32. AAA+ ATPase p97/VCP mutants and inhibitor binding disrupt inter-domain coupling and subsequent allosteric activation.
Caffrey B; Zhu X; Berezuk A; Tuttle K; Chittori S; Subramaniam S
J Biol Chem; 2021 Oct; 297(4):101187. PubMed ID: 34520757
[TBL] [Abstract][Full Text] [Related]
33. Detailed structural insights into the p97-Npl4-Ufd1 interface.
Isaacson RL; Pye VE; Simpson P; Meyer HH; Zhang X; Freemont PS; Matthews S
J Biol Chem; 2007 Jul; 282(29):21361-9. PubMed ID: 17491009
[TBL] [Abstract][Full Text] [Related]
34. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains.
Ye Y; Meyer HH; Rapoport TA
J Cell Biol; 2003 Jul; 162(1):71-84. PubMed ID: 12847084
[TBL] [Abstract][Full Text] [Related]
35. New ATPase regulators--p97 goes to the PUB.
Madsen L; Seeger M; Semple CA; Hartmann-Petersen R
Int J Biochem Cell Biol; 2009 Dec; 41(12):2380-8. PubMed ID: 19497384
[TBL] [Abstract][Full Text] [Related]
36. VCP/p97 increases BMP signaling by accelerating ubiquitin ligase Smurf1 degradation.
Li H; Cui Y; Wei J; Liu C; Chen Y; Cui CP; Li L; Zhang X; Zhang L
FASEB J; 2019 Feb; 33(2):2928-2943. PubMed ID: 30335548
[TBL] [Abstract][Full Text] [Related]
37. Complex of Fas-associated factor 1 (FAF1) with valosin-containing protein (VCP)-Npl4-Ufd1 and polyubiquitinated proteins promotes endoplasmic reticulum-associated degradation (ERAD).
Lee JJ; Park JK; Jeong J; Jeon H; Yoon JB; Kim EE; Lee KJ
J Biol Chem; 2013 Mar; 288(10):6998-7011. PubMed ID: 23293021
[TBL] [Abstract][Full Text] [Related]
38. A conserved protein with AN1 zinc finger and ubiquitin-like domains modulates Cdc48 (p97) function in the ubiquitin-proteasome pathway.
Sá-Moura B; Funakoshi M; Tomko RJ; Dohmen RJ; Wu Z; Peng J; Hochstrasser M
J Biol Chem; 2013 Nov; 288(47):33682-33696. PubMed ID: 24121501
[TBL] [Abstract][Full Text] [Related]
39. Structural basis of ubiquitin-independent PP1 complex disassembly by p97.
van den Boom J; Marini G; Meyer H; Saibil HR
EMBO J; 2023 Jul; 42(14):e113110. PubMed ID: 37264685
[TBL] [Abstract][Full Text] [Related]
40. Structural basis for the interaction between human Npl4 and Npl4-binding motif of human Ufd1.
Nguyen TQ; My Le LT; Kim DH; Ko KS; Lee HT; Kim Nguyen YT; Kim HS; Han BW; Kang W; Yang JK
Structure; 2022 Nov; 30(11):1530-1537.e3. PubMed ID: 36087575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
